National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Insurance Coverage: Arizona
    Posted: 12/19/2002    Reviewed: 12/17/2008
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma

For more information about insurance coverage of clinical trial costs, see this feature's main page: States That Require Health Plans to Cover Patient Care Costs in Clinical Trials.


Legislation: Senate Bill 1213

Effective: January 2001

What clinical trials are covered?

Phase I, II, III, and IV clinical trials for treatment, palliation (supportive care) (supportive care) or prevention of cancer approved by one of the following:

  • National Institutes of Health (NIH)
  • NIH cooperative group or center
  • U.S. Food and Drug Administration (in the form of an Investigational New Drug Application)
  • U.S. Department of Defense
  • U.S. Department of Veterans Affairs
  • A qualified research entity that meets NIH criteria for grant eligibility
  • A panel of qualified clinical research experts from academic health institutions in the state.

Who is required to pay?

  • Private insurers and managed care plans.

Other key criteria:

  • Trial must be reviewed and approved by an Institutional Review Board of an institution in Arizona.
  • Health professional must agree to accept reimbursement from the insurer as payment in full.
  • There is no clearly superior, noninvestigational treatment alternative.
  • Excludes coverage for trials outside of Arizona.

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov